Vimarsana
Biggest News Aggregation in the World

Page 21 - Genevant Sciences News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Genevant Sciences. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Genevant Sciences Today - Breaking & Trending Today

Overnight Health Care — Presented by Alexion — Pfizer effectiveness drops in younger kids - Vimarsana News

Overnight Health Care — Presented by Alexion — Pfizer effectiveness drops in younger kids

Welcome to Monday's Overnight Health Care, where we’re following the latest moves on policy and news affecting your health.

Arbutus files patent infringement lawsuit against Moderna - Vimarsana News

Arbutus files patent infringement lawsuit against Moderna

(Reuters) - Arbutus Biopharma Corp said on Monday it had filed a lawsuit against Moderna Inc seeking damages for infringement of patents related to it...

Source: wsau.com
Arbutus files patent infringement lawsuit against Moderna related to COVID shot - Vimarsana News

Arbutus files patent infringement lawsuit against Moderna related to COVID shot

Breaking News, Latest News and Current News from OANN.com. Breaking news and video. Latest Current News: U.S., World, Entertainment, Health, Business, Technology, Politics, Sports.

Source: oann.com
Roivant Sciences Up 28%, Continuing Increase - Vimarsana News

Roivant Sciences Up 28%, Continuing Increase

By Josh Beckerman Roivant Sciences Ltd. shares recently traded up 28% to $14.02, following gains in the previous four sessions. The biotechnology company didn't appear to issue any press... | December 20, 2021

ST Pharm in talks with Moderna over contract manufacturing of COVID-19 vaccine - Vimarsana News

ST Pharm in talks with Moderna over contract manufacturing of COVID-19 vaccine

By Baek Byung-yeul, Kim Yoo-chul Korean biotechnology firm, ST Pharm, is in talks with Moderna to produce messenger RNA (mRNA) COVID-19 vaccines, sources familiar with the matter told The Korea Times, Tuesday. "ST Pharm is in talks with Moderna to produce its mRNA vaccines following approval by the Ministry of Food and Drug Safety," one source said on condition of anonymity. ST Pharm declined to comment on the possibility of signing a contract manufacturing organization (CMO) deal with Moderna. "ST Pharm plans to apply liquid nanoparticle (LNP)-based drug substance technology for its RNA va...